Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00205491
Status:
COMPLETED
Last Update Posted:
2017-03-17
First Post:
2005-09-12
Brief Title:
Pharmacological Intervention in Depression After Traumatic Brain Injury
Sponsor:
Virginia Commonwealth University
Organization:
Virginia Commonwealth University
Study Overview
Official Title:
Pharmacological Intervention in Depression After Traumatic Brain Injury A Research Study Within the Traumatic Brain Injury Model System
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if treatment with venlafaxine reduces symptoms of depression in persons with traumatic brain injury
Detailed Description:
The study evaluates the benefits of a promising antidepressant medication for the treatment of persons with traumatic brain injury TBI and major depressive disorder MDD The study is a randomized double-blind placebo-controlled trial of venlafaxine a serotonin and norepinephrine reuptake inhibitor also known as Effexor Venlafaxine has been well established in the treatment of MDD in healthy individuals and is a recommended depression treatment agent for persons with TBI By using a rigorous scientific methodology this study will be an important first step in advancing the treatment of depression in this population beyond general impressions to proven treatments
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| H133A020516 | None | None | None |